Cart
sales@molnova.com
Faxeladol
CAS No. 433265-65-7
Faxeladol( —— )
Catalog No. M34595 CAS No. 433265-65-7
Faxeladol, a potent adrenergic absorption inhibitor and serotonin reuptake inhibitor, is a small-molecule Opioid receptor agonist that can be used to study neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 770 | In Stock |
|
| 10MG | 867 | In Stock |
|
| 25MG | 1007 | In Stock |
|
| 50MG | 1209 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFaxeladol
-
NoteResearch use only, not for human use.
-
Brief DescriptionFaxeladol, a potent adrenergic absorption inhibitor and serotonin reuptake inhibitor, is a small-molecule Opioid receptor agonist that can be used to study neurological disorders.
-
DescriptionFaxeladol, a potent adrenergic absorption inhibitor and serotonin reuptake inhibitor, is a small-molecule Opioid receptor agonist that can be used to study neurological disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAdrenergic Receptor
-
RecptorAdrenergic Receptor | Opioid Receptor | 5-HT Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number433265-65-7
-
Formula Weight233.35
-
Molecular FormulaC15H23NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N(C)C)[C@H]1[C@@H](CCCC1)C2=CC(O)=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
5-Bromoimidazo[1,2-A...
5-Bromoimidazo[1,2-a]pyrazine inhibits phosphodiesterase and beta-adrenergic receptors.5-Bromoimidazo[1,2-a]pyrazine shows antibronchospastic activity in vitro.
-
ADRA1D receptor anta...
ADRA1D receptor antagonist 1 HCl is an orally active, potent and selective α1D adrenergic receptor antagonist (Ki: 1.6 nM) with potential antiproliferative activity.
-
Taprizosin
Taprizosin（UK-338003） is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.
